Page 12 - Pharma

Online sales of health insurance to grow 15-20 times by 2020: Study

Smart cards & unique patient identifier for policyholders to drive digitisation of health insurance in India, according to FICCI-QuintilesIMS study

Strides Shasun buys Perrigo's APIs facility in India for Rs 100 crore

The company intends to transfer all the integrated DMFs filed for captive consumption to the acquired facility, which is located in Ambernath (Maharashtra) and is US FDA-approved

PolyPeptide buys Lonza's peptides business

The acquisition will enhance PolyPeptide's manufacturing capacity of peptides, which, like proteins, are naturally occurring chains of amino acids

Custom medical moulder Flexan acquires Medron

The addition of Medron will significantly enhance Flexan's contract manufacturing service offerings in the field of medical devices

IVI to fund development of Inovio's MERS vaccine

International Vaccine Institute (IVI) will add technical, laboratory and financial support for clinical trials of GLS-5300, a MERS (Middle East Respiratory Syndrome) vaccine

Dipankar Bhattacharjee to head Teva's global generics business

Bhattacharjee, who has served as president and CEO of Teva Generics Europe since April 2013, succeeds Sigurdur Olafsson

Global drug market to reach $1.5 trillion in 2021: Study

Most global spending growth will be fuelled by significant innovations in oncology, autoimmune and diabetes treatments, according to QuintilesIMS Institute research

Clariant to tap Indian pharma sector with packaging and anti-counterfeit solutions

The company, which is setting up a healthcare packaging production facility in Cuddalore, has launched technology to combat counterfeiting in medical devices and packaging

Lupin receives US FDA pain killer drug

The approved product, hydrocodone bitartrate and acetaminophen tablet, is a generic equivalent of Allergan Sales LLC's Norco tablet

Dr Reddy's launches antifungal skin cream in US

The product is the generic equivalent of Taro Pharmacueticals' nystatin and triamcinolone acetonide cream

Zydus plans to launch ulcer drug mesalamine in US by March 2020

This follows a settlement of the patent litigation related to Allergan's Delzicol (mesalamine)

Revised Indian e-visa policy to benefit medical tourism industry

The Government of India's decision to expand the scope of e-tourist visas, and include short term medical needs, will make India a destination of choice for patients from across the world

ICMR and ICAR to collaborate for research on zoonotic diseases

Medical and agricultural research institutes ink MoU for cooperation in the area of zoonoses, anti-microbial resistance, nutrition and pesticide residues

IFC invests Rs 450 cr in Apollo Health

AHLL will use this fund to expand its network of Apollo Clinics (multi-specialty clinics), Apollo Cradle (women & children hospitals) and Apollo Diagnostics centres across India

Lupin to market Eli Lilly's insulin analog product in India

The Mumbai-based pharma company will market and sell Eglucent, a new brand of Lilly's insulin analog Lispro, while Eli Lilly will be responsible for manufacturing and import

Q Holding buys medical catheters maker Degania Silicone

By acquiring Degania, which has a production facility in India, Q Holding will strengthen its position as the leading global supplier of engineered elastomeric products to healthcare sector

Lupin receives US FDA nod for sleep disorder drug armodafinil

The approved product is a generic version of Cephalon Inc's Nuvigil tablet, which recorded annual US sales of $ 515.6 million

Patheon acquires Roche's APIs manufacturing site in US

It will provide Patheon with a major APIs operation in the US capable of supporting products from clinical scale to commercial manufacturing

Sun Pharma launches first branded ophthalmic product BromSite in US

Developed by its California-based subsidiary, InSite Vision, the product is also the first bromfenac ophthalmic solution formulated in DuraSite, a polymer-based drug delivery system

Pfizer to launch new products under Corex brand

At the same time, the company will discontinue the production of the current Corex cough syrup formulation (a combination of codeine phosphate and chlorpheniramine maleate)